Genome-Wide Occupancy of SREBP1 and Its Partners NFY and SP1 Reveals Novel Functional Roles and Combinatorial Regulation of Distinct Classes of Genes by Reed, Brian D. et al.
Genome-Wide Occupancy of SREBP1 and Its Partners
NFY and SP1 Reveals Novel Functional Roles and
Combinatorial Regulation of Distinct Classes of Genes
Brian D. Reed
1, Alexandra E. Charos
1, Anna M. Szekely
2, Sherman M. Weissman
2, Michael Snyder
1,3*
1Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, Connecticut, United States of America, 2Department of Genetics, Yale
University School of Medicine, New Haven, Connecticut, United States of America, 3Molecular Biophysics and Biochemistry Department, Yale University, New Haven,
Connecticut, United States of America
Abstract
The sterol regulatory element-binding protein (SREBP) family member SREBP1 is a critical transcriptional regulator of
cholesterol and fatty acid metabolism and has been implicated in insulin resistance, diabetes, and other diet-related
diseases. We globally identified the promoters occupied by SREBP1 and its binding partners NFY and SP1 in a human
hepatocyte cell line using chromatin immunoprecipitation combined with genome tiling arrays (ChIP-chip). We find that
SREBP1 occupies the promoters of 1,141 target genes involved in diverse biological pathways, including novel targets with
roles in lipid metabolism and insulin signaling. We also identify a conserved SREBP1 DNA-binding motif in SREBP1 target
promoters, and we demonstrate that many SREBP1 target genes are transcriptionally activated by treatment with insulin
and glucose using gene expression microarrays. Finally, we show that SREBP1 cooperates extensively with NFY and SP1
throughout the genome and that unique combinations of these factors target distinct functional pathways. Our results
provide insight into the regulatory circuitry in which SREBP1 and its network partners coordinate a complex transcriptional
response in the liver with cues from the diet.
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Introduction
The transcription factor SREBP1 is a key regulator of the
transcription of numerous genes that function in the metabolism of
cholesterol and fatty acids [1]. Alternative promoter usage gives rise
to two nearly identical isoforms of SREBP1—SREBP1a and
SREBP1c—that differ from each other at a few N-terminal amino
acids encodedby different first exons [2].Both isoforms begin as ER
membrane-bound precursors and require proteolytic cleavage to
release N-terminal fragments that function in the nucleus [3]. Levels
of nuclear SREBP1a increase in response to cholesterol depletion
through a sterol-sensing pathway that determines the rate of
cleavage [3]. In contrast, levels of nuclear SREBP1c increase in
response to insulin signaling [4,5] and stimulation of the nuclear
receptor LXRa [6]—inputs that upregulate the transcription of
SREBP1c. SREBPs are weak transcriptional activators on their own
and interact with their target promoters in cooperation with
additional regulators, most commonly including one or both of the
transcription factors NFY and SP1 [7–9].
Excessive accumulation of fatty acids in the liver is associated
with a number of diet-related diseases such as insulin resistance,
metabolic syndrome, and type 2 diabetes. The de novo synthesis of
fatty acids (lipogenesis) in the liver is induced by the insulin
signaling pathway. Numerous studies based on the analysis of
single genes have demonstrated that SREBP1 upregulates the
transcription of lipogenic genes, primarily through the insulin-
responsive SREBP1c isoform which predominates in the liver [1].
Although these studies have identified a number of important
lipogenic genes that are regulated by SREBP1, our understanding
of the targets of SREBP1 involved in lipid metabolism is
incomplete and the role of SREBP1 in other pathways that may
contribute to diet-related disease states is poorly understood.
Furthermore, our understanding of the manner in which SREBP1
selects and regulates its target genes in combination with other
transcriptional regulators is limited.
In the present study, we sought to further understand the
function of SREBP1 and how it operates with other regulators by
globally mapping its target genes and those of its associated factors
NFY and SP1 in human hepatocarcinoma (HepG2) cells using
ChIP-chip. In addition, we sought to correlate SREBP1
occupation with changes in gene expression induced under
conditions in which SREBP1 is activated and repressed. The
overall scheme is depicted in Figure 1A.
Results/Discussion
Genome-Wide Identification and Characterization of
SREBP1 Binding Sites in Human Promoters
The physiological levels of hepatic SREBP1c are downregulated
in the fastedstate and dramatically upregulateduponrefeedingwith
high carbohydrates [10]. Therefore, to identify the complete
repertoire of hepatic SREBP1 target genes using ChIP-chip, we
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mimic the high-carbohydrate refeeding response. We then
performed chromatin immunoprecipitation with a well-character-
ized antibody that recognizes both SREBP1 isoforms due to their
nearly identical primary structure. Since both isoforms are present
in the nucleus under these conditions, the bindingprofilesgenerated
include targetsofbothSREBP1a and SREBP1c.Afteramplification
and fluorescent labeling, the immunoprecipitated DNA was
hybridized to NimbleGen human promoter tiling arrays. These
arrays contain 50-mer oligonucleotide probes tiled at 100 bp
resolution from 1200 bp upstream to 300 bp downstream of the
transcriptional start sites of approximately 16,700annotated human
genes. Examples of the enrichment profiles generated at represen-
tative SREBP1 target promoters are shown in Figure 1B. Statistical
analysis of four replicate experiments using a hidden Markov model
approach [11] provided evidence for SREBP1 occupation at the
promotersof1141genes(TablesS1andS2).Theinteractiondataset
exhibited a striking enrichment (approximately 9-fold) for known
targets of SREBP1 (P=1.4610
229, hypergeometric test)—37 genes
occupied by SREBP1 in our analysis have been previously
characterized as SREBP1 targets in the liver (Table S3). This
subset includes 18 out of19 representedSREBP1 target genes in the
cholesterol biosynthesis pathway (Figure 2A) as well as known target
genes involved in fatty acid biosynthesis and the pentose phosphate
pathway (a pathway that supplies the NADPH required for lipid
synthesis).
To determine the accuracy of our ChIP-chip results, we selected
a random set of 19 putative SREBP1 binding sites and performed
quantitative PCR using site-specific primers (Table S4). Binding
was confirmed for 17 of these sites (Figure S1).
We next performed an unbiased search for DNA sequence motifs
representing protein-DNA interaction sites in the set of SREBP1
target sequences using the program MDScan [12]. The top-scoring
motif discovered in this search (Figure 2B) was 10 bp in length and
contained an E-box consensus CANNTG known to bind basic
Figure 1. Study design and ChIP enrichment at representative SREBP1-occupied promoters. A) Overall scheme to identify targets of
SREBP1, NFY, and SP1 in HepG2 cells and to investigate the regulation of SREBP1 targets under opposing nutrient conditions. B) SREBP1 targets were
identified using ChIP-chip with promoter tiling arrays; three representative SREBP1-occupied promoters are shown. Smoothed log2 ChIP enrichment
values of tiled DNA probes are represented by vertical bars. Upper plots represent ChIP enrichment with an SREBP1-specific antibody whereas lower
plots represent ChIP enrichment with rabbit IgG used as a negative control. Array hybridizations of unenriched (input) DNA were used as a reference
for calculating ChIP enrichment. Chromosomal positions are indicated on the x-axis. Gene structure is shown to scale below each plot with 59-UTRs
(black boxes), exons (grey boxes) and introns (black lines) indicated.
doi:10.1371/journal.pgen.1000133.g001
Author Summary
Transcription factors (TFs) are DNA-binding proteins that
regulate the transcription of their target genes. TFs
typically bind in proximity to the transcription start sites
of their target genes in a region called the promoter.
SREBP1 is a TF that increases the transcription of numerous
genes involved in cholesterol and fat metabolism and has
been linked to diet-related diseases such as insulin
resistance and type 2 diabetes. Using microarray technol-
ogy, we identified all of the promoters in the human
genome that are bound by SREBP1 and two associated TFs
called NFY and SP1 in a human liver cell line. Our findings
greatly expand the number of genes and biological
pathways that may be regulated by SREBP1 and reveal
that different combinations of SREBP1 and its partners
preferentially target genes involved in different pathways.
Thus, in contrast to traditional studies that focus on
individual genes, we have used a genomics approach to
provide a novel global view of the regulatory circuitry in
which SREBP1 and its partners coordinate a transcriptional
response in the liver with cues from the diet.
Genome-Wide Occupancy of SREBP1
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comparison of the discovered motif to the TRANSFAC [14]
database using a motif comparison and alignment algorithm [15]
identified the known SREBP1 consensus E-box motif as the most
similar match (Figure 2B and Figure S2). To investigate the
evolutionary sequence conservation of SREBP1 binding sites, we
scanned the set of SREBP1-occupied promoters and a set of
randomly selected promoters for matches to the discovered motif.
The matching 10 bp DNA sequences identified in SREBP1 target
promoters exhibited significantly higher levels of conservation
across vertebrate species (P=3.0610
23) based on their phastCons
conservation scores [16] than matching sequences in the randomly
selectedpromoter set (Figure 2C). Thus, the binding sites and motifs
identified are likely to have a functional role in vivo.
To determine the fraction of SREBP1-occupied genes that is
potentially transcribed in HepG2 cells, we performed ChIP-chip
with an antibody that recognizes the initiating form of RNA
polymerase II. Our results revealed that 43% (n=7070) of the
genes on the promoter array were occupied by RNA polymerase II
(Figures S1 and S2). As expected, the vast majority of SREBP1
target genes (88%, n=1007) were also occupied by RNA
polymerase II (Figure 2D).
Novel and Expanded Functional Roles for SREBP1
To explore the cellular processes that are regulated by SREBP1,
we examined the functional categories associated with SREBP1
targets genes based on annotations in the Gene Ontology (GO)
[17] database and manual curation and identified enriched GO
categories using the BiNGO program [18] (Figure S3 and Table
S5). Genes associated with lipid metabolism were highly enriched
in the interaction dataset (P=1.5610
24), consistent with the
known functions of SREBP1. Inspection of these genes revealed 41
novel SREBP1 targets (Table S6), considerably expanding the
repertoire of SREBP1-regulated genes involved in lipid metabo-
lism. One important target that we identified in this category,
ADIPOR2, encodes the primary liver receptor for the insulin-
sensitizing adipocytokine adiponectin [19]. Intriguingly, ADIPOR2
expression is inversely regulated by insulin in hepatocytes [20],
suggesting that SREBP1 may play a repressive role at the
ADIPOR2 promoter. Other important targets include endothelial
lipase (LIPG), a key player in HDL metabolism [21], ethanolamine
kinase 1 (ETNK1), an enzyme that catalyzes the first committed
step in phosphatidylethanolamine synthesis, and sterol O-acyl-
transferase 2 (SOAT2), an enzyme responsible for cholesterol
esterification in the liver [22].
Further investigation of the functions of novel SREBP1 target
genes suggested that SREBP1 plays a more expansive role in a
number of other processes in which it has been previously
implicated. For example, SREBP1 is known to regulate the
expression of IRS2 [23] and PIK3R3 [24], components of the
insulin signaling pathway. We identified promoter interactions
with several additional components of this pathway, including
AKT1S1, AKT2, GRB2, GSK3A, MEKK2, PRKCQ (also known as
PKCh), and S6K1. These interactions suggest that SREBP1 is
involved in complex feedback regulation of insulin signaling and
implicate SREBP1 in additional branches of the insulin signaling
Figure 2. Key features of SREBP1 target genes and binding sites. A) The cholesterol biosynthesis pathway with key intermediates indicated
in blue text and enzymes represented by their gene symbols. Blue circles indicate genes identified as SREBP1 targets by ChIP-chip. *The promoters of
mevalonate pyrophosphate decarboxylase (MVD) and sterol-C4 methyl oxidase (SC4MOL) were not represented on the promoter array.
{The
squalene epoxidase (SQLE) promoter narrowly missed our significance thresholds; we confirmed SREBP1 binding by ChIP-qPCR. B) The top-scoring
motif discovered in an unbiased analysis of SREBP1-occupied promoter sequences using MDScan [12] (top) compared to the known E-box-containing
SREBP1 consensus from the TRANSFAC [14] database (bottom). C) Evolutionary conservation of DNA sequences matching the discovered E-box motif.
Boxplots represent the median and interquartile range of the maximum phastCons conservation scores [16] of 10 bp matching sequences located in
the set of SREBP1-occupied promoters (dark blue) or in an equally-sized set of random promoters (light blue). The conservation score (ranging from 0
to 1) represents the probability that a base is in a conserved element [16]. The increase in conservation of matching sequences in SREBP1-occupied
promoters is significant (P=3.0610
23 using a Wilcoxon rank-sum test). D) Venn diagram illustrating the overlap among SREBP1-occupied genes, RNA
Pol II-occupied genes, and the total set of genes represented on the promoter tiling array.
doi:10.1371/journal.pgen.1000133.g002
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recent studies have identified SREBP1a as a transcriptional
activator of the cyclin-dependent kinase inhibitor gene CDKN1A
(also known as p21)—an interaction that likely provides a crucial
link between the synthesis of membrane lipids and cell
proliferation [25]. Our findings support the role of SREBP1 in
linking these processes, as 60 genes associated with cell cycle
regulation based on GO annotation were identified among
SREBP1 targets. Important cell cycle regulators occupied by
SREBP1 include ABL1, CCNG2, CDC25C, CDK2, and E2F4.
Finally, the targets of SREBP1 were enriched (P=1.1610
23) for
genes involved in cellular respiration (e.g. CYCS, IDH3G, SUCLA2,
SDHB, and MDH1), providing insight into the role of SREBP1 in
energy metabolism and expanding on the known regulatory
interaction of SREBP1 with the mitochondrial aconitase gene
ACO2 [26].
The list of SREBP1 target genes was also enriched for genes in a
variety of GO categories that have not previously been associated
with SREBP1, including RNA processing (P=1.1610
211), protein
transport (P=8.1610
26), and DNA metabolism (P=3.0610
22).
Taken together, our results suggest that SREBP1 may be involved
in coordinating the activity of a wide range of cellular pathways
with nutrient availability at the transcriptional level.
Gene Expression Analysis of SREBP1 Target Genes
In the liver, the expression of many known SREBP1c target
genes is downregulated in the fasted state when SREBP1c levels
are reduced and upregulated upon high carbohydrate refeeding
when SREBP1c levels increase [10]. To determine whether the
putative direct targets of SREBP1 identified by ChIP-chip are
differentially expressed in the fasted and refed states, we performed
gene expression analysis. Levels of mRNA were compared
between HepG2 cells treated with insulin and glucose (in the
same manner as cells used for ChIP-chip analysis) or with forskolin
and dexamethasone—molecules that reproduce the counter-
regulatory effects of glucagon and cortisol in the fasted state.
The gene expression changes induced by these treatments were
consistent with those observed in the fasted and refed liver in vivo
(Table S7). To compare the list of SREBP1 targets with the gene
expression dataset, the expression dataset was rank-ordered by fold
change such that the most highly-induced genes in the refed state
were at the top of the ranked list. We observed a marked
enrichment of SREBP1 targets among the top ranking genes
within this ranked list (Figure 3A). To determine whether this
biased distribution of SREBP1 targets was statistically significant
in comparison to the distribution expected at random, we used
Gene Set Enrichment Analysis (GSEA) [27]. GSEA revealed that
the enrichment of SREBP1 targets at the top of the ranked list was
statistically significant (P,10
23) and identified a subset of 555
SREBP1-occupied genes that accounted for this effect (Figure 3A
and Table S8). To highlight the most strongly induced SREBP1
targets in this subset, all SREBP1-occupied genes exhibiting
greater than 1.75-fold induction in the refed state (71 total) are
shown in Figure 3B; notably, 31% of these genes are known targets
of SREBP1. These observations strongly indicate that transcrip-
tional activation is the predominant effect of SREBP1 binding.
Although SREBP1 binding sometimes results in gene repression,
as previous studies have demonstrated for a few genes such as IRS2
[23] and PCK1 [28], repressed targets are less frequent than
induced targets and fail to exhibit significant enrichment in our
dataset. Importantly, our results demonstrate that a substantial
proportion of the direct targets of SREBP1 identified by ChIP-
chip are activated by insulin and glucose in the refed state.
Combinatorial Regulation of Distinct Classes of Genes by
SREBP1 and Its Partners NFY and SP1
To begin to investigate the regulatory networks in which
SREBP1 operates, we performed location analysis with antibodies
that recognize the transcription factors NFY and SP1—two key
partners involved in the control of many SREBP1 target genes [7–
9]. These ChIP-chip experiments were also performed in HepG2
cells treated with insulin and glucose as described above for
SREBP1 and revealed that NFY and SP1 occupied the promoters
of 1707 and 1641 genes, respectively (Tables S1 and S2).
Comparison of these genes with the set of SREBP1-occupied
targets revealed a high degree of overlap (Figure 4A); 32% of
SREBP1 targets were occupied by NFY and 34% were occupied
by SP1. In total, 48% of SREBP1 targets were occupied by at least
one other transcription factor. The regulatory circuitry among
SREBP1, NFY, and SP1 was highly interconnected (Figure 4B).
For example, SP1 participates in multicomponent loops with both
SREBP1 and NFY, an arrangement wherein two factors occupy
each other’s promoters. In addition, all three factors exhibited
autoregulation, a hallmark of master regulators of key cellular
processes [29]. Finally, these factors bind upstream of many other
transcription factor genes, including the SREBP family member
SREBP2, suggesting that SREBP1, NFY, and SP1 are involved in
transcriptional regulatory cascades that can operate on additional
target genes and pathways in an indirect manner.
We next used Gene Ontology to investigate the functions of
genes targeted by different combinations of SREBP1 and its
associated factors. This type of analysis is important for expanding
our currently limited understanding of how transcriptional
regulatory networks are organized into functional modules in
mammalian genomes. Identification of enriched GO categories
using BiNGO [18] revealed that different combinations of these
regulators display distinct preferences for genes involved in certain
biological pathways (Figure 4C and Table S9). In some cases, these
pathways were targeted by a unique combination of regulators.
For example, genes involved in lipid metabolism, including
important lipogenic genes such as stearoyl-CoA desaturase 1,
were preferentially occupied by the combination of SREBP1 and
NFY (P=2.4610
23). Likewise, genes involved in carbohydrate
metabolism (P=1.5610
22) and cellular respiration
(P=2.5610
22), key nutrient-regulated pathways, were enriched
among targets of SREBP1 alone, indicating that SREBP1 may
cooperate with regulators other than NFY and SP1 at the
promoters of these genes. In some cases, however, one biological
pathway was targeted by multiple combinations of regulators. For
example, genes encoding cholesterol biosynthetic enzymes were
enriched among targets of all three regulators (P=3.0610
26) and
among targets of both SREBP1 and NFY (P=3.9610
24). This
type of configuration may reflect differences among genes in the
same pathway, such as their timing or responsiveness to different
stimuli. Additional representative enriched categories for each
combination of regulators are displayed in Figure 4C. It will be of
interest to determine how SREBP1 participates in the control of
different biological pathways in combination with a wider array of
transcriptional regulators in the liver by performing location
analysis for additional factors, especially those that participate in
nutrient-regulated pathways, such as SREBP2, LXRa, PPARa,
and ChREBP.
In conclusion, these studies present the first global analysis of
targets of an important set of regulators involved in mammalian
lipid metabolism. The targets of SREBP1 are involved in a wide
array of cellular processes suggesting new and expanded roles for
this transcription factor. In addition, many of these targets are
differentially regulated in the fasted and refed states, suggesting
Genome-Wide Occupancy of SREBP1
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SREBP1 and its associated factors NFY and SP1 form an
interconnected regulatory circuit and bind in a combinatorial
manner to functionally distinct sets of target genes.
Materials and Methods
Cell Culture
HepG2 cells were routinely cultured in DMEM supplemented
with 10% FBS and 100 U/ml penicillin/streptomycin. For ChIP-
Figure 3. Gene expression changes of SREBP1 targets in fasted and refed HepG2 cells. A) Correlation of ranked gene expression data with
SREBP1 occupancy. Left panel, replicate expression measures of 14,857 genes ranked by fold induction in the refed state are displayed as a heatmap.
Middle panel, the corresponding percentage of genes occupied by SREBP1 in a 2000 gene sliding window. The dashed line indicates the expected
percentage (i.e. the overall percentage of interrogated genes occupied by SREBP1). Right panel, GSEA [27] enrichment score plot. The enrichment
score is a running sum statistic that, beginning with the top-ranking gene, increases when an SREBP1 target gene is encountered and decreases
otherwise [27]. Enrichment of SREBP1 targets at the top of the ranked list results in a large positive deviation of the enrichment score from zero,
indicated by the dotted line. In total, 555 out of 1066 represented SREBP1-occupied genes are located above this line and account for the significant
(P,10
23) association of SREBP1 targets with the top of the ranked list. B) Detailed view of 71 SREBP1 target genes exhibiting greater than 1.75-fold
higher expression in the refed state. Replicate expression measures are shown as a heatmap with the corresponding SREBP1 enrichment from ChIP-
chip and gene symbol displayed on the right. Gene symbols of known SREBP1 target genes are indicated in red.
doi:10.1371/journal.pgen.1000133.g003
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free DMEM with 0.5% BSA for 12 h then treated with either
insulin (100 nM) and glucose (10 mM) or with forskolin (1 mM),
dexamethasone (1 mM), and pyruvate (2 mM) for 6 h in glucose-
free DMEM with 0.5% BSA.
Chromatin Immunoprecipitation
ChIP was performed as described with modifications [30].
Briefly, for each ChIP reaction, ,5610
7 HepG2 cells were
crosslinked for 15 min at room temperature, washed twice in cold
PBS and swollen for 15 min on ice in hypotonic buffer. Nuclei
were then pelleted and resuspended in lysis buffer for 30 min on
ice followed by sonication using a Branson 450 Sonifier set at 50%
amplitude. Samples were sonicated 8 times for 20 sec with 1–
2 min on ice between pulses. Extracts were clarified by
centrifugation at 14,000 rpm for 15 min at 4uC, pre-cleared with
50 ml of Protein A/G beads (Pierce) for 1 hr at 4uC, then
incubated overnight with 10 mg of the appropriate specific or
negative control antibody at 4uC. Antibodies used were rabbit
anti-SREBP1 (sc-8984), rabbit anti-NFYA (sc-10779), rabbit anti-
SP1 (sc-59), and normal rabbit IgG (sc-2027) obtained from Santa
Cruz, and mouse anti-RNA Pol II (MMS-126R) obtained from
Covance. Antibody-bound complexes were then captured by
incubation with 50 ml of Protein A/G beads. Beads were washed
once with RIPA buffer (150 mM NaCl), once with high-salt RIPA
buffer (500 mM NaCl), twice with LiCl detergent, and once with
TE. Antibody-bound complexes were then eluted by incubation
with 100 ml of elution buffer (100 mM NaHCO3/1%SDS) for
15 min with gentle vortexing followed by a second 15 min elution
with 150 ml of elution buffer. The eluates were combined and
treated with RNaseA (20 mg/ml) for 1 hr at 37uC then incubated
overnight at 65uC to reverse crosslinks. Whole cell extract DNA
was also treated for crosslink reversal. Samples were then digested
with Proteinase K (20 mg/ml) for 2 h at 37uC and DNA was
purified by one extraction with phenol, one extraction with
phenol/chloroform/isoamyl alcohol and one extraction with
chloroform/isoamyl alcohol followed by ethanol precipitation
and Qiagen PCR purification. Purified DNA was blunt-ended,
ligated to universal linkers, and amplified using ligation-mediated
PCR. Amplified DNA was then labeled with Cy3 or Cy5 dyes and
hybridized to NimbleGen human promoter tiling arrays (array
design ‘‘2005-04-18_HG17_min_promoter_set’’) according to the
manufacturer’s protocol (NimbleGen Systems of Iceland).
Promoter Tiling Array Analysis
Four biological replicate hybridization datasets (provided in
Dataset S1) were generated for transcriptional regulators (ChIP),
negative control rabbit IgG (control), and unenriched (input) DNA
using an unpaired reference design. For SREBP1, NFY, and SP1,
log2-transformed probe intensities were quantile normalized across
the set of IP, control, and input replicate groups. For RNA Pol II,
log2-transformed intensities werequantile normalized withingroups
then scaled to have a median feature intensity of 10. Normalized
intensities were analyzed using a two-state Hidden Markov Model
(HMM) in the program TileMap [11]. Briefly, TileMap first
computes a test-statistic for every probe based on a hierarchical
empirical Bayes model then uses HMM to combine information
from neighboring probesand calculatetheposterior probability that
a probe is in the enriched state [11]. The enriched state was defined
as: (ChIP.control) AND (ChIP.input). Enriched regions were
selected by taking a posterior probability cutoff of 0.90 and merging
probes separated by less than 500 bp. Regions less than 100 bp in
length or containing fewer than 5 probes were discarded. A
summary enrichment score was calculated for each region by taking
the maximum probe value of mean(ChIP)-mean(input). Regions
were matched to the closest RefSeq transcripts within 1500 bp on
each strand based on the refGene table (hg17, May 2004 assembly)
downloaded from the UCSC Table Browser (http://genome.ucsc.
edu/) [31]. Entrez GeneIDs were assigned to transcripts via the
refLink conversion table (hg17, May 2004 assembly).
Target Validation
Quantitative PCR with site-specific primers was performed in
duplicate on a BioRad MyiQ real-time PCR cycler with BioRad
iQ SYBR Green supermix. Primers were designed for 19
randomly selected SREBP1 target promoters and for a negative
control unbound region in exon 4 of the GAPDH gene.
Normalized Ct (DCt) values for each sample were calculated by
subtracting the Ct value obtained using input DNA from the Ct
value obtained using SREBP1 ChIP DNA (DCt=CtChIP–Ctinput).
Fold enrichment was then calculated using the formula
2
2(DCt[target]2DCt[GAPDH]). For the purpose of estimating the
specificity of the SREBP1 ChIP-chip dataset, promoters with an
average qPCR fold enrichment greater than 2 were considered
enriched. Primer sequences are listed in Table S4.
Figure 4. Genome-wide co-occupancy of SREBP1 with network
partners NFY and SP1. A) Venn diagram showing the overlap among
the sets of SREBP1-, NFY-, and SP1-occupied genes. B) Network diagram
of the regulatory interactions observed among SREBP1, NFY, and SP1.
Arrows indicate direct binding of one regulator to the promoter of
another regulator or to its own promoter. Arrows to SREBP1 were
determined by ChIP-qPCR with primers for the SREBP1c promoter as this
promoter was not represented on the promoter array. C) Combinatorial
regulation of SREBP1 target genes. Enriched GO categories were
identified in each set of SREBP1 target genes occupied by a distinct
combination of factors (or by SREBP1 alone) using BiNGO [18]. The
number of genes with GO annotation within each set is indicated in
parentheses. Representative enriched GO categories and their P-values
are displayed for each regulator combination; the entire set of enriched
GO categories for each combination is listed in Table S9.
doi:10.1371/journal.pgen.1000133.g004
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The motif discovery program MDScan [12] was used to identify
candidate protein-DNA interaction motifs in the SREBP1 dataset.
Input to the MDScan program consisted of 200bp sequences
centered on the probe exhibiting maximum enrichment in each
bound region. The top-scoring motif from MDScan was queried
against the TRANSFAC database using the STAMP web server
(http://www.benoslab.pitt.edu/stamp) [15] to identify the best
matching known motifs. Results are presented in Figure S2. The
DNA consensus sequence logos in Figure 2B were generated with
the WebLogo tool (http://weblogo.berkeley.edu/).
Functional Classification
Statistical analysisoftheenrichmentofGene Ontologycategories
(‘Biological Process’ branch) was performed using BiNGO (http://
www.psb.ugent.be/cbd/papers/BiNGO/) [18]. Enrichment was
determined in reference to all Entrez GeneIDs annotated in the
Biological Process branch (13,460 genes total). P-values are derived
from a hypergeometric test followed by Benjamini and Hochberg
false discovery rate correction. A P-value cutoff of 0.05 was used to
identify significantly enriched categories.
Gene Expression Analysis
Total RNA from 5610
6 fasted or refed HepG2 cells was
collected using Trizol (Invitrogen) and further purified using a
Qiagen RNeasy kit. Purified total RNA from two biological
replicate experiments was then submitted to the Affymetrix
Resource at the Yale W.M. Keck Foundation Biotechnology
Resource Laboratory for labeling and hybridization to Affymetrix
human genome U133 Plus 2.0 arrays. The robust multiarray
averaging method [32] in the Bioconductor affy package [33] was
used to generate expression measures from probe-level data.
Updated probe set definitions were used to map expression data to
the EntrezGene database [34]. For heatmap display, log2-
transformed gene expression measures were ranked by expression
difference (mean[refed]-mean[fasted]), mean centered, and visu-
alized using Java Treeview (http://jtreeview.sourceforge.net/).
The complete expression dataset is summarized in Table S7.
Comparison of ChIP-chip and Gene Expression Data
To visualize the distribution of SREBP1 target genes within the
ranked gene expression dataset, we generated a running overlap plot
by sliding a 2000 gene window down the ranked list and calculating
the percent overlap between the two datasets in each window. The
significance of the association of SREBP1 target genes with the top of
the ranked list was assessed using Gene Set Enrichment Analysis
(GSEA)software[27].Briefly,amaximumenrichmentscore(ES)was
derived for the SREBP1 target gene set by taking the maximum
deviation from zero of a running-sum statistic computed by walking
downthe ranked list and increasing the running-sum statistic when an
SREBP1 target gene was encountered and decreasing it otherwise (as
detailed in ref. [27]). The magnitude of the maximum ES reflects the
degree to which a gene set is overrepresented at the extremes of the
ranked list. The ranked list was then randomized 1000 times,
calculating the maximum ES for each permutation in order to derive
a null distribution. The nominal P-value for the SREBP1 target gene
set (P,10
23) represents the fraction of scores in the null distribution
that are at least as high as the observed maximum ES.
Conservation Analysis
The set of SREBP1-bound DNA sequences (500 bp regions
centered at the peak of ChIP enrichment) was scanned for matches
to the PWM discovered by MDScan using the PatSearch web
program (http://www.ba.itb.cnr.it/BIG/PatSearch/) with a sim-
ilarity threshold of 0.80. The same procedure was performed for
an equally-sized set of 500 bp regions selected at random from the
promoters represented on the promoter array. The maximum 8-
way phastCons conservation score [16] of each match in SREBP1-
bound and random regions was then obtained using the Galaxy
web server (http://main.g2.bx.psu.edu/). Scores from the
SREBP1-bound and random regions were compared using a
Wilcoxon rank-sum test.
Supporting Information
Figure S1 Validation of SREBP1 binding by quantitative PCR.
SREBP1 ChIP DNA was compared to input DNA to determine
ChIP enrichment at 19 randomly selected SREBP1-occupied
promoters. Bar heights represent qPCR enrichment at each
promoter using site-specific primers. Error bars represent the
standard deviation of replicate experiments. The dotted line
indicates the fold enrichment cutoff used to determine whether a
promoter was enriched or unenriched in the SREBP1 ChIP DNA.
Primer pairs are listed in Table S3.
Found at: doi:10.1371/journal.pgen.1000133.s001 (0.02 MB PDF)
Figure S2 Motif similarity matches in the TRANSFAC
database. The motif discovered by MDScan in SREBP1-bound
sequences (Motif1) was compared to the TRANSFAC database
using a motif comparison and alignment algorithm on the STAMP
web server (http://www.benoslab.pitt.edu/stamp). The top 5
matches are shown, ranked in order of the significance (E value)
of the pairwise alignment between the input motif and the
TRANSFAC database motif.
Found at: doi:10.1371/journal.pgen.1000133.s002 (0.51 MB PDF)
Figure S3 Network visualization of enriched functional catego-
ries. Significantly enriched Gene Ontology categories (‘Biological
Process’ branch) in the SREBP1 dataset are shown with their
hierarchical relationships represented as a directed acyclic graph
drawn using the BiNGO program (http://www.psb.ugent.be/
cbd/papers/BiNGO/). Nodes are colored by P-value as indicated.
Node size corresponds to the number of genes within each
category. P-values are derived from a hypergeometric test followed
by false discovery rate correction. A P-value cutoff of 0.05 was
used to identify significantly enriched nodes. Some category labels
are not shown for clarity.
Found at: doi:10.1371/journal.pgen.1000133.s003 (0.40 MB PDF)
Table S1 Chromosome coordinates of regions bound by
SREBP1, POL2, NFY, and SP1. A summary enrichment score
and position of peak enrichment are listed for each region. Results
for each factor are displayed on separate worksheets.
Found at: doi:10.1371/journal.pgen.1000133.s004 (0.84 MB
XLS)
Table S2 Binding sites of SREBP1, POL2, NFY, and SP1
matched to Refseq transcripts and their associated Entrez
GeneIDs. The results for each factor are displayed on separate
worksheets. Known SREBP1 target genes are highlighted in blue.
A complete list of Entrez GeneIDs represented on the promoter
array is also provided.
Found at: doi:10.1371/journal.pgen.1000133.s005 (2.96 MB
XLS)
Table S3 Known SREBP target genes identified in a compre-
hensive literature search. The column titled ‘‘Liver target’’
indicates whether there is (1) or is not (0) evidence that a gene is
targeted by SREBPs in the rodent or human liver. The column
titled ‘‘SREBP1 ChIP-chip target’’ indicates whether or not a
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chip dataset. Putative hepatic targets that are represented on the
promoter array are shaded in gray. A literature reference for each
regulatory interaction is also provided.
Found at: doi:10.1371/journal.pgen.1000133.s006 (0.06 MB
XLS)
Table S4 Site-specific primers used for qPCR validation of
SREBP1 binding sites.
Found at: doi:10.1371/journal.pgen.1000133.s007 (0.03 MB
XLS)
Table S5 Results of BiNGO used to identify enriched Gene
Ontology categories among genes occupied by SREBP1.
Found at: doi:10.1371/journal.pgen.1000133.s008 (0.08 MB
XLS)
Table S6 SREBP1 target genes identified by ChIP-chip that are
involved in cellular lipid metabolism based on Gene Ontology
annotations.
Found at: doi:10.1371/journal.pgen.1000133.s009 (0.02 MB
XLS)
Table S7 Results of gene expression analysis. Each row displays
a gene represented by probesets on the Affymetrix expression
array, the (log2) expression measures in refed and fasted HepG2
cells (two replicates each), and the overall expression difference
(mean[refed]-mean[fasted]). Selected examples of genes exhibiting
expression changes that are consistent with the physiological fasted
and fed states are highlighted in blue.
Found at: doi:10.1371/journal.pgen.1000133.s010 (2.71 MB
XLS)
Table S8 Results of Gene Set Enrichment Analysis. For each
SREBP1 target gene, the corresponding rankand fold change inthe
Affymetrixfastedvs.refed gene expression dataset is indicated along
with the value of the running-sum statistic (Running ES) at that
point in the ranked list (see Materials and Methods). In addition,
genes inthe leading-edgesubset(Core enrichment=Yes), whichare
responsibleforthebiaseddistributionofSREBP1targetgenesinthe
ranked list, are highlighted in green.
Found at: doi:10.1371/journal.pgen.1000133.s011 (0.18 MB
XLS)
Table S9 Results of BiNGO used to identify enriched Gene
Ontology categories among genes occupied by different combina-
tions of SREBP1 and its associated factors NFY and SP1. Results
for each combination are represented on separate worksheets.
Found at: doi:10.1371/journal.pgen.1000133.s012 (0.08 MB
XLS)
Dataset S1 Raw log2 probe intensities for each replicate
hybridization of ChIP, control, and input DNA. The genomic
location of each probe is indicated in columns 1–3.
Found at: doi:10.1371/journal.pgen.1000133.s013 (17.01 MB
ZIP)
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